Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 17.227.287.747.993.97

What is the latest Working Capital/Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest Working Capital/Sales ratio of GLENMARK PHARMACEUTICALS is 17.22 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar202417.22
Mar20237.28
Mar20227.74
Mar20217.99
Mar20203.97

How is Working Capital/Sales of GLENMARK PHARMACEUTICALS Trending?

Years Working Capital/Sales % Change
Mar2024 17.22
136.54
Mar2023 7.28
-5.94
Mar2022 7.74
-3.13
Mar2021 7.99
101.26
Mar2020 3.97 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Working Capital/Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,842.8 Cr 4.8% 5.2% 40% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,273.0 Cr 2.9% 1.8% 14% Stock Analytics
DIVIS LABORATORIES ₹166,750.0 Cr 5.7% 9.6% 58.6% Stock Analytics
CIPLA ₹121,122.0 Cr -0.8% 1.2% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,487.0 Cr 0.8% 1.2% 25.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,680.0 Cr 2.9% 6.5% 4.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4.8%

5.2%

40%

SENSEX

3.6%

9.5%

13.3%


You may also like the below Video Courses